Collaborative Research. Collective Progress.
The NYGC is an independent nonprofit established through strong relationships and affiliations with leading medical and academic institutions in New York and beyond.
Core Areas of Concentration
Our approach is guided by a commitment to uncovering the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric conditions. With a strategic focus on biology, genomics, and cutting-edge technology, we contribute to the advancement of healthcare through scientific research.
Cultivating Interinstitutional Collaboration
We have conducted clinical diagnostic testing and over 2,200 genomics research projects in collaboration with academic institutions, disease foundations, and industry, including major pharmaceutical companies. Through these strategic partnerships, we look to accelerate knowledge creation and discovery to impact the scientific and medical communities and advance our mission.
Groundbreaking Research
We cultivate a diverse research community dedicated to advancing the understanding of genomic science and the treatment of human disease.
-
Cancer Research
We push forward the leading edge of cancer genomics research by focusing on whole genome sequencing of individuals with cancer and their tumors, novel population-level cancer analytics, and the application of both single-cell and spatial transcriptomics.
-
Neurodegenerative Disease Research
We leverage the success of our Center for Genomics of Neurodegenerative Disease's focus on ALS research to extend our work across a wider range of neurodegenerative diseases that, despite their diverse clinical manifestations, share common pathways with ALS; such diseases include vascular dementia, Alzheimer's disease, frontotemporal dementia, Parkinson's disease, and Huntington's disease.
-
Neuropsychiatric Disease Research
Using whole genome sequencing, we will broaden our robust research of the genetic architecture of autism to include the study of additional neuropsychiatric disorders such as schizophrenia and bipolar disorder.
-
Biology, Genomics & Technology
We advance the development and deployment of novel genomic technologies, including molecular diagnostic testing, liquid biopsy, single-cell analysis, CRISPR gene editing, spatial transcriptomics, and other laboratory computational methods.
-
Scientific Collaboration & Project Management
We collaborate with partners to plan a successful genomics research project from inception to completion. We are flexible and creative, and work to meet the needs of our partners by designing tailor-made collaborations covering a spectrum of opportunities.
